Table of Contents  
NEWS AND VIEWS
Year : 2013  |  Volume : 4  |  Issue : 3  |  Page : 223-224  

Baldness, a new marker for coronary heart disease risk


Department of Pharmacology, Indira Gandhi Medical College and Research Institute, Kadhirkamam, Puducherry, India

Date of Web Publication5-Jul-2013

Correspondence Address:
G Sivagnanam
Department of Pharmacology, Indira Gandhi Medical College and Research Institute, Kadhirkamam, Puducherry
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
Sivagnanam G. Baldness, a new marker for coronary heart disease risk. J Pharmacol Pharmacother 2013;4:223-4

How to cite this URL:
Sivagnanam G. Baldness, a new marker for coronary heart disease risk. J Pharmacol Pharmacother [serial online] 2013 [cited 2019 Nov 22];4:223-4. Available from: http://www.jpharmacol.com/text.asp?2013/4/3/223/114620


   New(S) Top


Male pattern baldness is linked to an increased risk of coronary heart disease (CHD), but only if it's on the top/crown of the head, rather than at the front. [1]


   (Re)Views Top


A positive association between male pattern baldness and insulin resistance, [2] metabolic syndrome, [3] and hypertension [4] have been shown earlier.

A meta-analysis of observational studies comprising a total of 36,690 participants showed that vertex baldness is associated with an increased risk of CHD with the relationship depending on the severity of baldness while frontal baldness is not. Thus, it has been suggested that, vertex baldness might be a marker of CHD and is more closely associated with systemic atherosclerosis. [5]

The effectiveness of minoxidil (vasodilator) only in vertex baldness and not in frontal baldness, [6] also supports the finding that vertex baldness is more closely related to atherosclerosis than frontal one. Though the reason for the association between baldness and CHD is unclear, the possible mechanisms suggested include hyperinsulinemia, chronic inflammation, and increased peripheral sensitivity to androgens.

Like blood grouping, why not the male type baldness grouped into the following categories?

  • O (vertex)
  • M (frontal)
  • OM (vertex and frontal)
  • Inverted U (O merged with M) and
  • T (Total)
  • Men of all groups except group M be wary of CHD.


 
   References Top

1.Available from: http://www.sciencedaily.com/releases/2013/04/ 130403200156.htm. [Last accessed on 2013 Apr 23].  Back to cited text no. 1
    
2.Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol 2011;21:79-82.  Back to cited text no. 2
[PUBMED]    
3.Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: A community-based survey. Br J Dermatol 2010;163:371-7.  Back to cited text no. 3
[PUBMED]    
4.Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol 2007;17:220-2.  Back to cited text no. 4
[PUBMED]    
5.Yamada T, Hara K, Umematsu H, Kadowaki T. Male pattern baldness and its association with coronary heart disease: A meta-analysis. BMJ Open 2013;3:e002537 doi:10.1136/bmjopen-2012-002537  Back to cited text no. 5
    
6.Scow DT, Nolte RS, Shaughnessy AF. Medical treatments for balding in men. Am Fam Physician 1999;59:2189-94, 2196.  Back to cited text no. 6
[PUBMED]    




 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
   New(S)
   (Re)Views
    References

 Article Access Statistics
    Viewed1040    
    Printed29    
    Emailed0    
    PDF Downloaded307    
    Comments [Add]    

Recommend this journal